Deucravacitinib treatment did not affect immune response to SARS-Cov-2 vaccines and infection in patients with plaque psoriasis: results from the Phase 3 POETYK long-term extension trial

被引：0
|
作者：
不详
机构：
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2024年 / 191卷
关键词：
D O I：
10.1093/bjd/ljae360.144
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P114
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Deucravacitinib Treatment Did Not Impact Immune Response to SARS-CoV-2 Vaccines and Infection in Patients with Plaque Psoriasis: Results from the Phase 3 POETYK Long-Term Extension Trial
    Winthrop, Kevin
    Merola, Joseph
    Morita, Akimichi
    Thaci, Diamant
    Zhang, Jianzhong
    Ba, Aditi Basu
    Catlett, Ian M.
    Schwarz, John
    Luo, Yi
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 4165 - 4167
  • [2] Deucravacitinib long-term efficacy and safety in plaque psoriasis: 2-year results from the phase 3 POETYK PSO program
    Spelman, Lynda
    Warren, Richard B.
    Sofen, Howard
    Imafuku, Shinichi
    Blauvelt, Andrew
    Toms, Jessica
    Buck, Alex
    Banerjee, Subhashis
    Menter, Alan
    Szepietowski, Jacek C.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2023, 64 : 28 - 28
  • [3] DEUCRAVACITINIB LONG-TERM EFFICACY AND SAFETY IN PLAQUE PSORIASIS: 2-YEAR RESULTS FROM THE PHASE 3 POETYK PSO PROGRAM
    Warren, R. B.
    Sofen, H.
    Imafuku, S.
    Szepietowski, J.
    Blauvelt, A.
    Spelman, L.
    Colston, E.
    Toms, J.
    Buck, A.
    Banerjee, S.
    Menter, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 841 - 841
  • [4] Deucravacitinib Long-term Efficacy and Safety in Plaque Psoriasis: 2-Year Results from the Phase 3 POETYK PSO Program
    Warren, Richard
    Sofen, Howard
    Imafuku, Shinichi
    Szepietowski, Jacek C.
    Blauvelt, Andrew
    Spelman, Lynda
    Toms, Jessica
    Buck, Alex
    Banerjee, Subhashis
    Menter, Alan
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 4230 - 4232
  • [5] Deucravacitinib (DEUC) Long-Term Efficacy with Continuous Treatment in Plaque Psoriasis: 2-Year Results from the Phase 3 POETYK PSO Study Program
    Thaci, Diamant
    Lebwohl, Mark
    Warren, Richard B.
    Sofen, Howard
    Imafuku, Shinichi
    Paul, Carle
    Szepietowski, Jacek
    Spelman, Lynda
    Passeron, Thierry
    Colston, Elizabeth
    Hippeli, Lauren
    Napoli, Andrew
    Kisa, Renata
    Banerjee, Subhashis
    Menter, Alan
    Blauvelt, Andrew
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 120 - 121
  • [6] Deucravacitinib Long-term Efficacy With Continuous Treatment in Plaque Psoriasis: 2-Year Results From the Phase 3 POETYK PSO-1 and POETYK PSO-LTE Trials
    Lebwohl, Mark
    Warren, Richard B.
    Kircik, Leon
    Colston, Elizabeth
    Hippeli, Lauren
    Napoli, Andrew
    Kisa, Renata M.
    Banerjee, Subhashis
    Menter, Alan
    Thaci, Diamant
    Blauvelt, Andrew
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB35 - AB35
  • [7] Deucravacitinib in plaque psoriasis: Four-year safety and efficacy results from the Phase 3 POETYK PSO-1, PSO-2 and long-term extension trials
    Armstrong, April W.
    Lebwohl, Mark
    Warren, Richard B.
    Sofen, Howard
    Morita, Akimichi
    Paul, Carle
    Papp, Kim A.
    Colombo, Matthew J.
    Scotto, Julie
    Vaile, John
    Zhuo, Joe
    Vritzali, Eleni
    Berger, Victoria
    Schroeder, Georgene
    Banerjee, Subhashis
    Thaci, Diamant
    Strober, Bruce
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2025,
  • [8] Deucravacitinib in Plaque Psoriasis: 4-Year Efficacy Results by Prior Biologic Treatment in the Phase 3 POETYK PSO-1, PSO-2, and Long-Term ExtensionTrials
    Warren, Richard
    Armstrong, April W.
    Imafuku, Shinichi
    Morita, Akimichi
    Paul, Carle
    Augustin, Matthias
    Passeron, Thierry
    Kircik, Leon
    Vritzali, Eleni
    Scharnitz, Thomas
    Schroeder, Georgene
    Banerjee, Subhashis
    Strober, Bruce
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 2310 - 2312
  • [9] Inflammatory Response in SARS-CoV-2 Infection of Patients with Schizophrenia and Long-Term Antipsychotic Treatment
    Moga, Silvia
    Teodorescu, Andreea
    Ifteni, Petru
    Gavris, Claudia
    Petric, Paula-Simina
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2021, 17 : 3053 - 3060
  • [10] Long-term evolution of humoral immune response after SARS-CoV-2 infection
    Teyssou, Elisa
    Zafilaza, Karen
    Sayon, Sophie
    Marot, Stephane
    Dropy, Margot
    Soulie, Cathia
    Abdi, Basma
    Tubach, Florence
    Hausfater, Pierre
    Marcelin, Anne-Genevieve
    Boutolleau, David
    CLINICAL MICROBIOLOGY AND INFECTION, 2022, 28 (07) : 1027.e1 - 1027.e4
12345